Latest Updates

Early hydrocortisone improves survival without bronchopulmonary dysplasia in extremely preterm born infants.

HYDROCORTISONE Postnatal steroids represent an attractive therapeutic option for BPD prevention in extremely preterm neonates, but questions remain about their safety. This randomized controlled trial assessed the safety and efficacy of intravenous low-dose hydrocortisone administration to prevent BPD in ELBW neonates at 24-27 weeks’ gestational age. The trial revealed that survival without BPD was significantly improved in neonates receiving hydrocortisone. While further study is required to determine its long-term neurodevelopmental effects, the trial suggests that hydrocortisone may be effective in preventing BPD in ELBW infants.

Does a comprehensive family-centred early intervention service affect stress reactivity and emotion regulation in very low birth weight preterm infants at toddler age?

BEHAVIORAL DEVELOPMENT Preterm infants are at risk for a broad spectrum of poor neurodevelopmental outcomes, including poor emotional regulation and stress response throughout childhood. This randomized controlled trial assessed whether a child-parent dyad-focused early intervention could improve primitive behaviors, reactivity, and stress response in ex-preterm toddlers. The trial found that home- or clinic-based intervention programs moderately improved primitive behavior and response to stress after interventions in the clinic or the home; however, further study is necessary to confirm these data.

EBNEO 2017

EBNEO 2017

Welcome to the 4th international Conference for Evidence-Based Neonatology, 10-12 November 2017, in Hyderabad India. It is now possible to register!

Read more

Membership

Membership

We welcome individuals and institutions around the world to sign up for a membership. An institutional membership grants employees to become individual members free of charge. All memberships are valid for one year. Institutions and individuals residing in developing countries, as defined by the UN, get a 50% fee discount. Read more information here on how…

Read more

About

About

The International Society for Evidence-Based Neonatology (EBNEO) is a non-profit organisation that nourishes a vision that all neonatal care should be firmly built on best available evidence. The vision includes as short a passage from research-based knowledge to implementation in neonatal care (translation), thereby improving survival, decreasing morbidities and promoting long-lasting health for newborn infants. Memberships are open for individuals and institutions from all around the world.

Read more